Home 5 Clinical Diagnostics Insider 5 New Test Aids Lung Cancer Risk Assessment, But Survival Benefit of Comprehensive Sequencing Questioned

New Test Aids Lung Cancer Risk Assessment, But Survival Benefit of Comprehensive Sequencing Questioned

by | Sep 14, 2018 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Special Focus-dtet

From - Diagnostic Testing & Emerging Technologies Lung cancer-related testing is receiving a lot of attention, but recent results appear to show mixed benefits for these emerging tests… . . . read more

Sign up for our free weekly Lab & Pathology Insider email newsletter

Subscribe to Clinical Diagnostics Insider to view

Start a Free Trial for immediate access to this article